Cargando…
Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children’s Research Hospital Approach
Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. In recent Total Therapy studies conducted at St. Jude Children’s Research Hospital, children with ALL had a 5-year overall survival of around 94%. This is the result of a combination of risk stratification based on the...
Autores principales: | Inaba, Hiroto, Azzato, Elizabeth M., Mullighan, Charles G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722984/ https://www.ncbi.nlm.nih.gov/pubmed/29255701 http://dx.doi.org/10.3389/fped.2017.00258 |
Ejemplares similares
-
Energy cost of walking in obese survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort
por: Wogksch, Matthew D., et al.
Publicado: (2022) -
Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020) -
Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16
por: Gruber, Tanja A., et al.
Publicado: (2022) -
St. Jude's Offertories
por: Parsons, William C.
Publicado: (1917) -
Late Outcomes in Survivors of Childhood Acute Myeloid Leukemia: A Report from the St. Jude Lifetime Cohort Study
por: Bhatt, Neel S., et al.
Publicado: (2021)